跳至主要内容
临床试验/NCT01514318
NCT01514318已完成不适用

A Long-term Follow Up Study of the Revelation™ Hip Stem

Encore Medical, L.P.1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
8
试验地点
1
主要终点
Survivorship of the Device

研究概览

简要总结

The purpose of this study is to obtain long-term (10+ yrs) clinical and patient outcomes data on patients who received the Revelation Hip Stem prior to 2002.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects must have received the Revelation™ Hip Stem as part of a total hip arthroplasty prior to
  • Surgery must have been a primary total hip replacement
  • Subject must have received only one primary hip replacement per hospitalization
  • Subject must have had a diagnosis of inflammatory tissue disorder, osteoarthritis, post-traumatic arthritis/secondary arthritis or avascular necrosis
  • Subject must be willing and able to sign the informed consent document

排除标准

  • Subject must not have had any previous hip implants (hemi or total joint)
  • Subject has a mental condition that may interfere with the ability to give an informed consent (i.e., severe mental retardation such that the subject cannot understand the informed consent process, global dementia, prior strokes that interfere with the subject's cognitive abilities, senile dementia, and Alzheimer's Disease)
  • Subject is a prisoner
  • Subject is pregnant

结局指标

主要结局

Survivorship of the Device

时间窗: 10 year

The subject meets the inclusion/exclusion criteria of the study and received a Revelation Hip Stem prior to 2002 that has survived intact without any type of surgery to revise or remove parts or the whole prosthesis.

次要结局

  • Western Ontario McMaster Arthritis Index (WOMAC)(10 year)
  • Harris Hip Score(10 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验